More than 200,000 glaucoma patients in over 80 countries have been treated since 2015 with MicroPulse® Transscleral Laser Therapy (TLT), which is performed using the MicroPulse P3® Delivery Device from Iridex . MicroPulse TLT can be introduced prior to, in conjunction with, or following all other glaucoma treatment options.
MicroPulse TLT can be performed in less than seven minutes and in an office setting or in the operating room, as determined by the physician. With MicroPulse technology, the laser is delivered in repetitive, low-energy laser ‘micropulses’ that are gentler than a continuous-wave laser.
The treatment causes minimal tissue damage; therefore, the doctor may repeat it as needed.